Stock Analysis on Net
Stock Analysis on Net

Boston Scientific Corp. (NYSE:BSX)

This company has been moved to the archive! The financial data has not been updated since May 4, 2023.

Common-Size Balance Sheet: Assets
Quarterly Data

Boston Scientific Corp., common-size consolidated balance sheet: assets (quarterly data)

Microsoft Excel
Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018
Cash and cash equivalents 1.73 2.86 1.06 0.86 1.01 5.97 6.11 8.58 6.52 5.63 6.56 5.59 1.23 0.71 1.04 0.51 0.58 0.70 0.82 1.06 1.49
Trade accounts receivable, net 6.31 6.07 5.86 5.96 5.77 5.52 5.24 5.37 5.28 4.97 5.18 4.73 5.24 5.98 6.71 7.04 6.81 7.66 7.75 8.09 8.23
Inventories 6.23 5.75 5.60 5.44 5.37 5.00 5.03 4.59 4.55 4.39 4.77 4.92 5.41 5.17 5.85 5.35 5.16 5.55 5.56 5.54 5.80
Prepaid income taxes 0.90 0.81 0.82 0.82 0.77 0.64 0.68 0.65 0.62 0.63 0.56 0.59 0.68 0.64 0.71 0.72 0.68 0.77 0.21 0.23 0.26
Assets held for sale 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 3.68 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other current assets 2.16 2.25 2.77 2.72 2.75 2.48 2.49 2.49 2.77 2.44 2.90 3.00 3.46 2.88 3.81 12.44 12.95 4.39 5.13 5.10 5.47
Current assets 17.34% 17.74% 16.10% 15.79% 15.66% 19.60% 19.54% 21.68% 19.74% 21.75% 19.97% 18.83% 16.02% 15.37% 18.12% 26.06% 26.19% 19.06% 19.49% 20.03% 21.25%
Property, plant and equipment, net 7.53 7.53 7.11 6.98 7.00 6.99 6.62 6.68 6.64 6.77 6.69 6.74 6.97 6.80 7.26 7.49 7.49 8.49 8.49 8.74 8.85
Goodwill 40.34 39.79 40.23 40.02 40.04 37.20 37.08 34.89 35.17 32.33 32.86 32.77 33.53 33.29 37.43 34.76 34.36 37.67 37.23 36.92 36.37
Other intangible assets, net 18.42 18.18 18.96 19.72 20.35 18.99 19.53 18.57 19.39 19.23 22.04 23.23 24.55 25.80 30.18 26.68 27.09 30.34 30.90 30.25 29.75
Deferred tax assets 11.86 12.14 12.58 12.61 12.69 12.85 12.70 12.95 13.50 13.68 13.53 13.57 13.82 13.73 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other long-term assets 4.50 4.62 5.01 4.87 4.25 4.37 4.53 5.23 5.55 6.24 4.91 4.86 5.11 5.00 7.02 5.01 4.87 4.43 3.89 4.05 3.78
Long-term assets 82.66% 82.26% 83.90% 84.21% 84.34% 80.40% 80.46% 78.32% 80.26% 78.25% 80.03% 81.17% 83.98% 84.63% 81.88% 73.94% 73.81% 80.94% 80.51% 79.97% 78.75%
Total assets 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%

Based on: 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31).

Balance sheet item Description The company
Current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Boston Scientific Corp. current assets as a percentage of total assets increased from Q3 2022 to Q4 2022 but then slightly decreased from Q4 2022 to Q1 2023.
Property, plant and equipment, net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. Boston Scientific Corp. property, plant and equipment, net as a percentage of total assets increased from Q3 2022 to Q4 2022 and from Q4 2022 to Q1 2023.
Long-term assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. Boston Scientific Corp. long-term assets as a percentage of total assets decreased from Q3 2022 to Q4 2022 but then slightly increased from Q4 2022 to Q1 2023.